How to treat hyponatremia (low sodium) in an outpatient with impaired renal function (GFR 43), hypercreatininemia (Cr 1.3), hyperkalemia (K 4.9), and taking furosemide (Lasix) 20mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To treat low sodium in this outpatient with moderate chronic kidney disease (GFR 43, Cr 1.3), I recommend fluid restriction to 1-1.5 liters per day as the primary intervention, as well as discontinuing the furosemide (Lasix) 20mg daily, which can contribute to hyponatremia, as suggested by the management of hypervolemic hyponatremia requiring attainment of a negative water balance 1. The patient's current sodium level of 130 mmol/L is below the normal range, and treatment should be initiated to prevent further complications.

  • The patient should be advised to avoid excessive free water intake and limit hypotonic fluids.
  • Dietary sodium should be moderately increased to 3-4g daily while monitoring for fluid retention.
  • Laboratory monitoring should be performed within 5-7 days to reassess sodium levels and kidney function.
  • If hyponatremia persists despite these measures, consider adding tolvaptan starting at 15mg daily with close monitoring, as the underlying cause of hyponatremia should be investigated, particularly given the patient's kidney disease 1.
  • The potassium level of 4.9 is at the upper limit of normal, so potassium intake should not be increased, especially if furosemide is discontinued.
  • It is essential to note that the management of hyponatremia requires careful consideration of the patient's volume status and kidney function, as hypertonic sodium chloride administration can worsen volume overload and ascites in patients with decompensated cirrhosis, but may be considered in severely symptomatic hyponatremia 1.
  • The guidelines for the diagnosis and treatment of acute and chronic heart failure also emphasize the importance of monitoring renal function and electrolytes, particularly when initiating or titrating medications such as ACE inhibitors or ARBs, which may affect kidney function and electrolyte balance 1.

From the FDA Drug Label

As with any effective diuretic, electrolyte depletion may occur during Furosemide tablets therapy, especially in patients receiving higher doses and a restricted salt intake All patients receiving Furosemide tablets therapy should be observed for these signs or symptoms of fluid or electrolyte imbalance (hyponatremia, hypochloremic alkalosis, hypokalemia, hypomagnesemia or hypocalcemia): dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, arrhythmia, or gastrointestinal disturbances such as nausea and vomiting. Potassium supplements and/or dietary measures may be needed to control or avoid hypokalemia. Serum electrolytes (particularly potassium), CO2, creatinine and BUN should be determined frequently during the first few months of Furosemide tablets therapy and periodically thereafter.

To treat low sodium (hyponatremia) in an outpatient with a GFR of 43, Cr of 1.3, K of 4.9, and Na of 130 who is taking lasix 20mg daily, the following steps can be considered:

  • Monitor the patient's serum electrolytes, particularly sodium and potassium, frequently.
  • Consider reducing or adjusting the lasix dose to minimize electrolyte depletion.
  • Provide the patient with guidance on dietary measures to control or avoid electrolyte imbalance.
  • Consider potassium supplements if necessary to avoid hypokalemia. It is essential to regularly check serum electrolytes, CO2, creatinine, and BUN to ensure that the patient's condition is not worsening 2.

From the Research

Treatment of Low Sodium in Outpatient Setting

The patient's lab results show a sodium level of 130 mmol/L, which is considered hyponatremic. The patient is also taking lasix 20mg daily, which is a loop diuretic that can exacerbate hyponatremia by increasing sodium loss in the urine.

Current Treatment Options

  • Fluid restriction: This is a common treatment for hyponatremia, but it may be difficult to implement in the outpatient setting 3.
  • Hypertonic saline solution: This can be used to rapidly correct severe hyponatremia, but it must be administered with caution to avoid overly rapid correction 4.
  • Loop diuretics: While the patient is already taking lasix, which is a loop diuretic, this class of medication can actually worsen hyponatremia by increasing sodium loss in the urine 4.
  • Vasopressin receptor antagonists: These medications, such as tolvaptan and conivaptan, can increase free-water excretion and correct hyponatremia by targeting the underlying mechanism of vasopressin excess 4, 5, 6.

Considerations for Treatment

  • The patient's underlying condition and the cause of the hyponatremia should be taken into account when selecting a treatment option.
  • The patient's kidney function, as indicated by the GFR of 43, should also be considered when selecting a treatment option.
  • The use of vasopressin receptor antagonists may be a promising treatment option for this patient, but more information is needed to determine the best course of treatment 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyponatraemia diagnosis and treatment clinical practice guidelines.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2017

Research

Vasopressin excess and hyponatremia.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.